Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anton Gartner
C. Elegans RAD-5/CLK-2 Defines a New DNA Damage Checkpoint Protein
Current Biology
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Neuroscience
Agricultural
TRT-1 Is the Caenorhabditis Elegans Catalytic Subunit of Telomerase
PLoS Genetics
Evolution
Ecology
Genetics
Molecular Biology
Cancer Research
Systematics
Behavior
‹
1
2
Related publications
Purification and Characterization of Human DNA Damage Checkpoint Rad Complexes
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Werner Syndrome Protein Homolog Affects C. Elegans Development, Growth Rate, Life Span and Sensitivity to DNA Damage by Acting at a DNA Damage Checkpoint
Development (Cambridge)
Developmental Biology
Molecular Biology
Replication Protein a Directs Loading of the DNA Damage Checkpoint Clamp to 5′-Dna Junctions
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
DNA-dependent Protein Kinase and Checkpoint Kinase 2 Synergistically Activate a Latent Population of P53 Upon DNA Damage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Correction: McK1 Kinase Is a New Player in the DNA Damage Checkpoint Pathway
PLoS Genetics
Evolution
Ecology
Genetics
Molecular Biology
Cancer Research
Systematics
Behavior
Interaxonal Interaction Defines Tiled Presynaptic Innervation in C. Elegans
Neuron
Neuroscience
Replication Protein a (RPA) SUMOylation Positively Influences the DNA Damage Checkpoint Response in Yeast
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
CDK1 Regulates Mediator of DNA Damage Checkpoint 1 During Mitotic DNA Damage
Cancer Research
Cancer Research
Oncology
Differential Roles of Checkpoint Kinase 1, Checkpoint Kinase 2, and Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Mediating DNA Damage-Induced Cell Cycle Arrest: Implications for Cancer Therapy
Molecular Cancer Therapeutics
Cancer Research
Oncology
